The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 27, 2016
Filed:
Aug. 21, 2014
Applicant:
Mycomagic Biotechnology Co., Ltd., New Taipei, TW;
Inventor:
Ying-Tzu Lyu, New Taipei, TW;
Assignee:
MYCOMAGIC BIOTECHNOLOGY CO., LTD., New Taipei, TW;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/80 (2006.01); C12N 15/33 (2006.01); C12N 7/00 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 39/0002 (2013.01); A61K 39/12 (2013.01); C12N 15/80 (2013.01); A61K 2039/60 (2013.01); C12N 2730/10034 (2013.01); C12N 2730/10134 (2013.01); C12N 2730/10151 (2013.01); C12N 2800/22 (2013.01);
Abstract
The invention provides a recombinant polynucleotide comprising a truncated glyceraldehyde-3-phosphate dehydrogenase (gpd) promoter and a modified HBV S protein gene and a transgeniccarrying the recombinant polynucleotide. The invention surprisingly found that after administering the transgenicto a subject, the subject can successfully generate an antibody against HBV. Therefore, the transgeniccan be used as a vaccine against HBV.